Paul Whiteley/ LinkedIn
Jun 24, 2026, 17:36
Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
Paul Whiteley, Autism Researcher, shared a post on X about a recent article by Abdelaziz Hendy et al. published in Evidence-Based Nursing, adding:
” ‘All children with fetal neonatal alloimmune thrombocytopenia should have long-term structured neurodevelopmental and autism screening even if they do not have an intracranial haemorrhage (ICH)‘
Another one of the autisms.
And following an immune disorder.”
Title: Are higher autism rates in FNAIT without intracranial haemorrhage real or a result of increased screening?
Authors: Abdelaziz Hendy, Abdulqadir J Nashwan
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering